Today: 9 June 2026
Browse Category

NASDAQ:ARCB 1 February 2026 - 4 February 2026

Old Dominion Freight Line stock price jumps as ODFL beats Q4 estimates and raises dividend

Old Dominion Freight Line stock price jumps as ODFL beats Q4 estimates and raises dividend

Old Dominion Freight Line shares jumped 8.8% to $206.38 Wednesday after the company beat quarterly earnings estimates and raised its dividend. Fourth-quarter LTL tons per day fell 10.7%, but revenue per hundredweight rose 4.9% excluding fuel. Revenue dropped 5.7% to $1.31 billion, while the operating ratio worsened to 76.7%. The board set the new quarterly dividend at 29 cents per share.
4 February 2026
······
ArcBest stock price jumped after a brutal earnings swing — what to watch next week

ArcBest stock price jumped after a brutal earnings swing — what to watch next week

ArcBest shares climbed 5.8% to $90.22 Friday, rebounding from a 6.6% drop after posting a fourth-quarter loss on a $9.1 million impairment charge. Revenue topped estimates at $972.7 million, but non-GAAP earnings missed forecasts. Goldman Sachs raised its price target to $100, citing tonnage growth. Investors await U.S. factory and jobs data for signals on freight demand.
1 February 2026
··

Stock Market Today

  • Yamaha Motor (TSE:7272) Stock Valuation and Recent Performance Analysis
    June 9, 2026, 11:53 AM EDT. Yamaha Motor's (TSE:7272) shares rose 10.3% over the past month, reflecting strong momentum with a 1-year total return of 15.1%. The stock closed recently at ¥1,230.5, slightly above the consensus analyst price target of ¥1,177, suggesting it may be 4.5% overvalued. Analysts show mixed views, with targets ranging from ¥1,000 to ¥1,500, hinging on expected earnings growth, margin improvements, and risks like rising labor and raw material costs, plus recall expenses. With ¥2.64 trillion in revenue and ¥26.7 billion net income, investors face the decision to buy amid uncertain margin pressure or await clearer signals. Monitoring risks and rewards closely is advised as the stock builds momentum amid market fluctuations.

Latest articles

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
Coupang Stock Gains as Privacy Ruling Approaches

Coupang Stock Gains as Privacy Ruling Approaches

9 June 2026
Coupang shares jumped 2% to $15.49, outperforming a falling market, as investors braced for South Korea’s privacy regulator to decide June 10 on possible sanctions over a data breach exposing 33.6 million records—a ruling that could trigger fines up to 3% of sales and impact the stock’s recovery.
AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

AEP’s $78 Billion Grid Plan Spurs Data Center Hopes

9 June 2026
AEP lifted its five-year capital plan to $78 billion after signing 7 gigawatts of new large-energy project agreements, with 90% of 63 gigawatts of expected incremental load by 2030 tied to data centers; shares recently traded at $127.27, up 26.9% over 52 weeks, with analysts’ mean price target at $142.76, as investors weigh execution risks and a new data-center rate structure.
Dow climbs in New York, but gains may stall

Dow climbs in New York, but gains may stall

9 June 2026
Dow jumps 154.87 points as tech rebounds and oil prices drop, with chipmakers like Intel and Broadcom up sharply; investors brace for Wednesday’s key inflation data and next week’s Fed meeting, which could sway rate expectations and market direction.
U.S. Stocks Hit Records This Week — Why the S&P 500 and Nasdaq Rally Survived the Oil Shock

Dow Up While Nasdaq Dips; AI Rally Meets Inflation Data

9 June 2026
Nuvalent soared after GSK agreed to buy the cancer drug developer for $10.6 billion in cash, valuing shares at $124—a 40% premium to Monday’s close—while investors awaited Wednesday’s key inflation data that could impact market direction and tech stock stability.
Go toTop